← Open Payments lookup

MADISON NASH: Open Payments

NPI 1407451271 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,924 in 54 payments from 16 companies in 2025. Trend: 2023 $907 · 2024 $722 · 2025 $1,924

Food & beverage: $1,892Education: $32
CompanyPaymentsAmount
ABBVIE INC.30$809
Madrigal Pharmaceuticals3$228
Eisai Inc.1$124
GENZYME CORPORATION1$122
Teva Pharmaceuticals USA, Inc.1$122
Janssen Biotech, Inc.3$105
Gilead Sciences, Inc.1$76
Takeda Pharmaceuticals U.S.A., Inc.2$63
PFIZER INC.2$51
Aimmune Therapeutics, Inc.2$44

Products named: SKYRIZI, REZDIFFRA, RINVOQ, Leqembi, DUPIXENT, TREMFYA, Livdelzi, ENTYVIO.

Industry payments across TX — which companies pay providers there.